Emerg Infect DisEmerging Infect. DisEIDEmerging Infectious Diseases1080-60401080-6059Centers for Disease Control and Prevention31538922675925919-048410.3201/eid2510.190484Letters to the EditorLetterSelf-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 TransmissionSelf-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 TransmissionSelf-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 TransmissionStylesClaire E.HoadVeronica C.Denham-RicksPaulaBrownDianneSeedClive R.Australian Red Cross Blood Service, Perth, Western Australia, Australia (C.E. Styles, V.C. Hoad, C.R. Seed); Australian Red Cross Blood Service, Melbourne, Victoria, Australia (P. Denham-Ricks, D. Brown)Address for correspondence: Claire E. Styles, Australian Red Cross Blood Service, GPO Box B80, Perth, Western Australia 6838, Australia; email: cstyles@redcrossblood.org.au102019251019961997Keywords: Human T-lymphotropic virus type 1blood donorsrisk factorsself-injurious behaviorvirusesAustralia

To the Editor: Blood donors in Australia who test positive for transfusion-transmissible infections, including human T-lymphotropic virus (HTLV), hepatitis B virus (HBV), hepatitis C virus, and HIV, undergo posttest counseling, as previously described (1). Similar to Tang et al. (2), we identified self-flagellation as a possible unique risk factor for HTLV-1 infection. History of self-flagellation was elicited in 7 (28%) of 25 HTLV-1–positive donors identified during January 2012–December 2018. All 7 donors were men 20–37 years of age, of whom 5 were born in Pakistan and 2 in India; 6 had given blood in Victoria, Australia. The 18 remaining HTLV-1–positive donors were 29–68 years of age; 10 (56%) were men; 1 was born in India and none in Pakistan; and 7 (39%) gave blood in Victoria.

HBV shares transmission routes with HTLV-1 and is highly infectious, including through minor blood exposures (3). After discussion of recognized infective risk factors, the 610 HBV-positive donors from the same period, of whom 83 were born in India or Pakistan, were asked about any other potential blood exposures. None reported self-flagellation.

At the time of posttest counseling, no previous HTLV results were available for donors reporting self-flagellation or for their family members. Until the known modes of vertical and sexual transmission have been excluded by such results, the likelihood of self-flagellation as an infective risk factor remains unclear. Although India and Pakistan are not known to be geographic risk areas for HTLV-1, few prevalence studies are available (4), and HTLV-1 is commonly present in small geographic foci (5). In addition, a noticeable degree of transmission through communal self-flagellation would first require a raised prevalence of infection among the practicing group. We look forward to further research that may clarify the apparent link between self-flagellation and HTLV-1 infection.

Suggested citation for this article: Styles CE, Hoad VC, Denham-Ricks P, Brown D, Seed CR. Self-flagellation as possible route of human T-cell lymphotropic virus type 1 transmission. Emerg Infect Dis. 2019 Oct [date cited]. https://doi.org/10.3201/eid2510.190484

Australian governments fund the Australian Red Cross Blood Service for the provision of blood, blood products, and services to the Australian community.

ReferencesPolizzotto MN, Wood EM, Ingham H, Keller AJ; Australian Red Cross Blood Service Donor and Product Safety Team. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion. 2008;48:5563.17894794Tang AR, Taylor GP, Dhasmana D. Self-flagellation as possible route of human T-cell lymphotropic virus type-1 transmission. Emerg Infect Dis. 2019;25:8113. 10.3201/eid2504.18098430882326Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384:205363. 10.1016/S0140-6736(14)60220-824954675Niazi SK, Bhatti FA, Salamat N. Seroprevalence of human T-cell lymphotropic virus-1/2 in blood donors in northern Pakistan: implications for blood donor screening. J Coll Physicians Surg Pak. 2015;25:8747.26691361Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388. 10.3389/fmicb.2012.0038823162541